Head and Neck Cancer Clinical Trials

The most recent listing of current clinical trials for head and neck cancer — including head and neck and thyroid — appears below. 

Site: Head and Neck (Includes Head and Neck and Thyroid)

Protocol ID    Title

BIOALLIANCE-BA2009-28-01    A Phase II, Multicentre, Randomised, Double-blind, Placebo-Controlled Study Comparing The Efficacy And Safety Of Clonidine Lauriad™ 50 Ìg And 100 Ìg Mucoadhesive Buccal Tablet (MBT) Applied Once Daily To Those Of Placebo In The Prevention And Treatment Of Chemoradiation Therapy Induced Oral Mucositis In Patients With Head And Neck Cancer

ECOG-1311    A Randomized, Placebo Controlled Phase II Trial of Afatinib (BIBW2992) as Adjuvant Therapy Following Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma at High Risk of Recurrence

ECOG-3311    Phase II Randomized Trial of Transoral Surgical Resection followed by Low-dose or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

LILLY-14E-MC-JXBA    Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Cisplatin in Patients with Recurrent or Metastatic Carcinoma of the Head and Neck

LILLY-14E-MC-JXBB    Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Carboplatin in Patients with Recurrent or Metastatic Carcinoma of the Head and Neck

RTOG-0920    A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally- Advanced Resected Head and Neck Cancer

RTOG-1008    A Randomized Phase II Study of Concurrent Intensity Modulated Radiation Therapy (IMRT), Paclitaxel and Pazopanib (NSC 737754) Placebo For the Treatment of Anaplastic Thyroid Cancer

RTOG-1016    Phase III Trial Of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy In HPV-Associated Oropharynx Cancer

RTOG-1216    Randomized Phase II/III Trial Of Surgery And Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel And Cetuximab For High-Risk Squamous Cell Cancer Of The Head And Neck

RTOG-1221    Randomized Phase II Trial of Transoral Endoscopic Head And Neck Surgery followed by Risk-Based IMRT and Weekly Cisplatin versus IMRT and Weekly Cisplatin for HPV Negative Oropharynx Cancer

RTOG-3501    Tryhard: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (TYKERB®) For Non-HPV Locally Advanced Head And Neck Cancer With Concurrent Chemoradiation

VRXP-A202    A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination with VTX-2337 in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck